Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Non-alcoholic Fatty Liver Disease

3,4-dihydroxyphenylacetic acid has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.

Research Excerpts

ExcerptRelevanceReference
"Non-alcoholic fatty liver disease (NAFLD) has been reported to induce cognitive impairments of hippocampus and may influence central nervous system."1.46Carnosic acid protects non-alcoholic fatty liver-induced dopaminergic neuron injury in rats. ( Ding, C; Shi, X; Xu, T; Yao, J; Zhang, N; Zhang, S; Zhao, Y; Zhou, J; Zhu, J, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xu, T1
Zhou, J1
Zhu, J1
Zhang, S1
Zhang, N1
Zhao, Y1
Ding, C1
Shi, X1
Yao, J1

Other Studies

1 other study available for 3,4-dihydroxyphenylacetic acid and Non-alcoholic Fatty Liver Disease

ArticleYear
Carnosic acid protects non-alcoholic fatty liver-induced dopaminergic neuron injury in rats.
    Metabolic brain disease, 2017, Volume: 32, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Abietanes; Alanine Transaminase; Animals; Aspartate Aminotransferase

2017